TWiV 887: Bonfire of the monocytes

TWiV explains why this season's influenza vaccine is not protecting against mild to moderate disease caused by H3N2 virus, and that antibody-dependent entry of SARS-CoV-2 into monocytes is a major contributor to severe COVID-19.

TWiV 886: COVID-19 clinical update #109 with Dr. Daniel Griffin

In COVID-19 clinical update #109, Daniel Griffin discusses cardiac complications after infection or vaccination, long COVID in children, fourth vaccine dose in Israel, no need for fourth vaccine dose in EU, dexamethasone dosing, immunomodulation therapy, MIS outcomes in children, US long COVID effort launched, and herd immunity.

A Viral Risk Factor for Multiple Sclerosis

Several new lines of evidence suggest that Epstein-Barr virus infection may be a risk factor for the development of multiple sclerosis.

TWiV 885: Russian bats and Ankara vectors

TWiV reveals an ACE2-dependent sarbecovirus from Russian bats that is not inhibited by anti-SARS-CoV-2 antibodies, and a modified vaccinia virus Ankara vectored vaccine that protects nonhuman primates from Delta infection.

Q&A with A&V Livestream 4/6/22 

Virologists Amy Rosenfeld and Vincent Racaniello answer your COVID-19 questions (or any virus questions) on this livestream of 4/6/22 at 8:30 PM eastern US.

TWiV 884: Cytokines and viral mimicry

Vincent and Amy explain how asthmatic bronchial smooth muscle increases rhinovirus replication in the bronchial epithelium, and mimicry of IL-17 by the ORF8 protein of SARS-CoV-2.

Trial By Error: Interview with Karen Hargrave, Co-Founder of #ThereForME

By David Tuller, DrPH Karen Hargrave is co-founder of an advocacy campaign called #ThereForME, which was launched this past summer to draw public awareness to the UK’s lack of care and treatment and to call “for an NHS [National Health Service] that’s there for people with ME and Long Covid.” The campaign has drawn significant …

Trial By Error: Interview with Karen Hargrave, Co-Founder of #ThereForME Read More »

Trial By Error: My Letter to BMJ Seeking Correction to Editorial on REGAIN Trial of Mental-and-Physical-Health Rehab for Long Covid

By David Tuller, DrPH I have recovered sufficiently from my post-election coma to send off another of my irritating letters to journals–this one to The BMJ. As I mentioned in a post earlier this week, The BMJ has corrected a major paper: “Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme …

Trial By Error: My Letter to BMJ Seeking Correction to Editorial on REGAIN Trial of Mental-and-Physical-Health Rehab for Long Covid Read More »

Trial By Error: Professor Chris Ponting on “Replicated Blood-Based Biomarkers” for ME in Big Data Pre-Print Study

By David Tuller, DrPH Along with several colleagues, Professor Chris Ponting, a geneticist at the University of Edinburgh and a leading ME/CFS researcher, recently posted a pre-print called “Replicated blood-based biomarkers for Myalgic Encephalomyelitis not explicable by inactivity.”  (A pre-print is a paper that has not yet been formally peer-reviewed.) For this analysis, the investigators …

Trial By Error: Professor Chris Ponting on “Replicated Blood-Based Biomarkers” for ME in Big Data Pre-Print Study Read More »

Trial By Error: The BMJ Corrects REGAIN Study’s Expansive Claims; Results Only Applicable to Post-Hospitalized Long Covid Patients

By David Tuller, DrPH In February, The BMJ published a study called Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial.” (Post-Covid-19 Condition, or PCC, is one of many current definitions for Long Covid.)The study, led by a team from …

Trial By Error: The BMJ Corrects REGAIN Study’s Expansive Claims; Results Only Applicable to Post-Hospitalized Long Covid Patients Read More »

Trial By Error: My Tour of Ireland, Through Wind and Rain; Slides of My Talk

By David Tuller, DrPH Last month, I took a quick speaking tour around Ireland at the invitation of the Irish ME/CFS Association. I first became acquainted with Tom Kindlon, the association’s assistant chairperson, about ten years ago. I was beginning to look into the background of the PACE trial, which purported to have proven the …

Trial By Error: My Tour of Ireland, Through Wind and Rain; Slides of My Talk Read More »

Trial By Error: Guardian Columnist George Monbiot on the “Bizarre Cult” at the London-Based Science Media Centre

By David Tuller, DrPH October is a crowdfunding month at University of California, Berkeley. If you’d like to support my work, you can make a donation to the university (tax-deductible for US taxpayers) here. Last week, Guardian columnist George Monbiot wrote another scathing piece about the failure of the UK health care system to address the …

Trial By Error: Guardian Columnist George Monbiot on the “Bizarre Cult” at the London-Based Science Media Centre Read More »

Scroll to Top